Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial urinary sphincter surgery in the UK: are we following the guidelines?

Annals of the Royal College of Surgeons of England·2025
Same author

Defining Standard Data Reporting in Pelvic Exenterations for Non-Rectal Cancers: A Systematic Review of Current Data Reporting.

Cancers·2025
Same author

Effects of variable heat rise/fall on MHD Maxwell ternary nanofluid (Copper-Alumina-Titanium Dioxide/Water) flow over a moving needle.

Scientific reports·2025
Same author

Knowledge and Belief about Antibiotic Use among Rural People of Bangladesh.

Mymensingh medical journal : MMJ·2025
Same author

Ethnomedicinal indices based ethno-veterinary plant profile of Yousaf Baba Hills, District Mohmand, Khyber Pakhtunkhwa, Pakistan.

Brazilian journal of biology = Revista brasleira de biologia·2025
Same author

Saying sorry - should a 'safe space' be created to allow effective communication between healthcare practitioners and aggrieved parties after an iatrogenic event in South Africa?

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2024
Same journal

Effective Mentorship in Urology Fellowship Training: Qualities, Models, and Equity.

Current urology reports·2026
Same journal

Management of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis.

Current urology reports·2026
Same journal

Lower Urinary Tract Symptoms as an Indicator of Occult Neurologic Disease: A System-first Framework for Urologic Practice.

Current urology reports·2026
Same journal

Association Between Ambient Temperature and Urolithiasis: A Systematic Review and Meta-analysis.

Current urology reports·2026
Same journal

Is Open Partial Nephrectomy Still an Option in the Robotic Era?

Current urology reports·2026
Same journal

Artificial Intelligence in Urologic Documentation: A Review of Emerging Capabilities and the Ongoing Need for Human Oversight.

Current urology reports·2026
See all related articles

Related Experiment Video

Updated: May 11, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

Botulinum toxin-what urologic uses does the data support?

J Seth1, M S Khan, P Dasgupta

  • 1Department of Uro-Neurology, UCL Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK. jai.seth@gstt.nhs.uk

Current Urology Reports
|April 30, 2013
PubMed
Summary
This summary is machine-generated.

Botulinum toxin-A (BTX-A) effectively treats lower urinary tract dysfunction (LUTD), including overactive bladder (OAB) and neurogenic detrusor overactivity (NDO). Recent studies show BTX-A improves urinary incontinence and quality of life, with specific doses proving efficacious for OAB.

Related Experiment Videos

Last Updated: May 11, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

Area of Science:

  • Urology
  • Pharmacology
  • Clinical Medicine

Background:

  • Botulinum toxin-A (BTX-A) is an established treatment for lower urinary tract dysfunction (LUTD).
  • OnabotulinumtoxinA is approved for neurogenic detrusor overactivity (NDO) and refractory idiopathic overactive bladder (OAB).

Purpose of the Study:

  • To review recent clinical studies on BTX-A for LUTD, focusing on OAB, detrusor overactivity (DO), benign prostatic hyperplasia (BPH), and painful bladder syndrome/interstitial cystitis (PBS/IC).

Main Methods:

  • Literature review of PubMed publications from January 2011 to present.
  • Inclusion of large randomized placebo-controlled trials and pooled analyses.

Main Results:

  • BTX-A improved urinary incontinence, urodynamic parameters, and quality of life in NDO patients.
  • OnabotulinumtoxinA (100 U) showed efficacy and acceptable safety for OAB.
  • BPH study results were mixed; PBS/IC requires further large-scale trials.

Conclusions:

  • BTX-A is effective for NDO and OAB, with specific dosing strategies.
  • Further research is needed for BTX-A in BPH and PBS/IC management.